The Real Winners

Not for the first time, GSK is mired in litigation

This week, GSK won a much-needed victory in a $640 million cancer lawsuit over the heartburn drug Zantac. However, thousands of lawsuits are still due to go to trial in the US. And there are thousands more to come.

Zantac became available in the 1980s before becoming an over-the-counter product. At one point, it was the world’s top-selling medicine, with…